GGrantIndex
Sort

23,748 grants matching melanoma

Biomarkers

$295,809
Janine G Einspahr · University Of Arizona · P01 · FY2015 · CA

IGF::OT::IGF RADIOIMMUNOTHERAPY OF MELANOMA WITH NOVEL LGG TO MELANIN

$295,782
Ph.d, David Rickles · · N43 · FY2016 · CA

PRECISION DIAGNOSTICS FOR EARLY MELANOMA DETECTION USING SPATIAL BIOLOGY AND AI-GUIDED IMAGE ANALYSIS

$295,740
The University Of Queensland · · FY2022 · Defense Health Agency

Mechanism and Inhibition of Collagenolytic Activity

$295,699
Gregg B Fields · University Of Texas Hlth Science Center · R01 · FY2009 · CA

Polymer Based Gene Delivery

$295,689
Alexander V Kabanov · University Of Nebraska Medical Center · R01 · FY2007 · CA

Cyclin D1 function in tumorigenesis and differentiation

$295,628
Mark E Ewen · Tufts Medical Center · R01 · FY2012 · CA

The Development of Screening Assays For Novel Inhibitors Of ARNO And Its Effector

$295,552
Dean Yaw Li · University Of Utah · R01 · FY2014 · CA

Reversing melanoma-induced T cell dysfunction

$295,501
Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2013 · CA

Validation of Grm1 as a Therapeutic Target in Melanoma

$295,488
James S Goydos · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2010 · CA

Validation of Grm1 as a Therapeutic Target in Melanoma

$295,488
James S Goydos · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2009 · CA

Validation of Grm1 as a Therapeutic Target in Melanoma

$295,488
James S Goydos · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2008 · CA

Molecular signatures of melanoma histology and progression: A Population Based A

$295,480
Abrar A Qureshi · Brigham And Women'S Hospital · R01 · FY2010 · CA

Nuclear receptors: action, functions, and roles in disease

$295,454
Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2018 · ES

Predicting Transcriptional and Epigenetic Networks in Cancer from Sequencing Data

$295,407
Jun S Song · University Of California, San Francisco · R01 · FY2013 · CA

Photoacoustic detection, capture, and analysis of circulating melanoma cells

$295,405
John A Viator · Duquesne University · R01 · FY2014 · CA

EP1 prostanoid receptor in ultraviolet carcinogenesis

$295,369
Ohio State University · R01 · FY2003 · CA

Project 1

$295,336
Kunle O Odunsi · Roswell Park Cancer Institute Corp · P50 · FY2021 · CA

Evading Immune Escape Mechanisms in Dual-Targeted T-cell Therapy for Breast Canc

$295,247
Juan Fernando Vera · Baylor College Of Medicine · P50 · FY2017 · CA

Pax3, Melanocyte Stem Cells and Melanoma

$295,150
Deborah Lang · University Of Chicago · R01 · FY2013 · CA

SSAT AS A DETERMINANT OF DRUG ACTION

$295,127
Roswell Park Cancer Institute Corp · R01 · FY2000 · CA

Targeting the NF-kappaB Pathway in Melanoma

$295,074
Ann Richmond · Vanderbilt University · R01 · FY2006 · CA

Combinatorial targeting of melanoma initiating cells

$295,070
Soldano Ferrone · Massachusetts General Hospital · R01 · FY2012 · CA

Crucial Microenvironmental Cofactors for Pancreatic Cancer Pathogenesis

$295,065
Eric Collisson · University Of California, San Francisco · R01 · FY2016 · CA

Promoting the generation of long-lived, anti-tumor memory T cells with IFN-alpha

$295,065
Willem W Overwijk · University Of Tx Md Anderson Can Ctr · R01 · FY2010 · CA

Crucial Microenvironmental Cofactors for Pancreatic Cancer Pathogenesis

$295,065
Eric Collisson · University Of California, San Francisco · R01 · FY2017 · CA